ACE2 and COVID-19: In addition, since it is responsible for metabolizing Ang II into Ang 1-7, a dominant mechanism for negative regulation on the RAAS, and for inactivating DABK, an inductor of pro-inflammatory repercussions of the KKS, ACE2 has relevant properties that have to be further explored as tools for the treatment of COVID-19 patients.